rs7295250

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000719.7(CACNA1C):​c.4623+995T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.424 in 151,978 control chromosomes in the GnomAD database, including 16,483 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 16483 hom., cov: 32)

Consequence

CACNA1C
NM_000719.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -4.30

Publications

5 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.05).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.709 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000719.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
NM_000719.7
MANE Select
c.4623+995T>C
intron
N/ANP_000710.5
CACNA1C
NM_001167623.2
MANE Plus Clinical
c.4623+995T>C
intron
N/ANP_001161095.1
CACNA1C
NM_199460.4
c.4767+995T>C
intron
N/ANP_955630.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
ENST00000399603.6
TSL:5 MANE Plus Clinical
c.4623+995T>C
intron
N/AENSP00000382512.1
CACNA1C
ENST00000399655.6
TSL:1 MANE Select
c.4623+995T>C
intron
N/AENSP00000382563.1
CACNA1C
ENST00000682544.1
c.4857+995T>C
intron
N/AENSP00000507184.1

Frequencies

GnomAD3 genomes
AF:
0.424
AC:
64380
AN:
151860
Hom.:
16462
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.716
Gnomad AMI
AF:
0.402
Gnomad AMR
AF:
0.429
Gnomad ASJ
AF:
0.334
Gnomad EAS
AF:
0.512
Gnomad SAS
AF:
0.360
Gnomad FIN
AF:
0.258
Gnomad MID
AF:
0.478
Gnomad NFE
AF:
0.274
Gnomad OTH
AF:
0.424
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.424
AC:
64445
AN:
151978
Hom.:
16483
Cov.:
32
AF XY:
0.425
AC XY:
31585
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.715
AC:
29654
AN:
41446
American (AMR)
AF:
0.429
AC:
6547
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.334
AC:
1159
AN:
3470
East Asian (EAS)
AF:
0.513
AC:
2635
AN:
5138
South Asian (SAS)
AF:
0.360
AC:
1735
AN:
4818
European-Finnish (FIN)
AF:
0.258
AC:
2728
AN:
10584
Middle Eastern (MID)
AF:
0.463
AC:
136
AN:
294
European-Non Finnish (NFE)
AF:
0.274
AC:
18596
AN:
67938
Other (OTH)
AF:
0.420
AC:
888
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1638
3276
4915
6553
8191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.331
Hom.:
29813
Bravo
AF:
0.455
Asia WGS
AF:
0.437
AC:
1522
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.1
CADD
Benign
0.043
DANN
Benign
0.24
PhyloP100
-4.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7295250; hg19: chr12-2776943; API